Last $106.36 USD
Change Today -0.12 / -0.11%
Volume 153.5K
TFX On Other Exchanges
New York
As of 8:04 PM 07/24/14 All times are local (Market data is delayed by at least 15 minutes).

teleflex inc (TFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/4/14 - $109.73
52 Week Low
08/16/13 - $74.42
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TELEFLEX INC (TFX)

Related News

No related news articles were found.

teleflex inc (TFX) Related Businessweek News

No Related Businessweek News Found

teleflex inc (TFX) Details

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company operates in three segments: Vascular, Anesthesia/Respiratory, and Surgical. It offers vascular access products that facilitate various critical care therapies, including the administration of intravenous medications and other therapies, the measurement of blood pressure, and taking of blood samples through a single puncture site; anesthesia products, such as airway management products under the LMA and Rusch brands, and pain management products under the Arrow brand; respiratory care products, such as oxygen therapy, aerosol therapy, spirometry, and ventilation management products under the Hudson RCI brand; and specialty products, including interventional access products, and products provided to specialty market customers. The company also provides surgical products, such as ligation and closure products used in surgical procedures; access ports for use in minimally invasive surgical procedures; fluid management products for use in chest drainage; and reusable hand-held instruments for general and specialty surgical procedures under the Deknatel, Pilling, Pleur-evac, Taut, and Weck brands. In addition, it offers cardiac care products comprising diagnostic catheters, including thermodilution and wedge pressure catheters; angiographic and therapeutic delivery catheters; sheaths for femoral and trans-radial aortic access, and intra-aortic balloons; and capital equipment, such as intra-aortic balloon pumps under the Arrow brand. Further, the company provides original equipment manufacturing and development services. Teleflex Incorporated offers its products to hospitals and healthcare providers in approximately 150 countries through its direct sales force and distributors. Teleflex Incorporated was founded in 1943 and is headquartered in Wayne, Pennsylvania.

11,400 Employees
Last Reported Date: 02/24/14
Founded in 1943

teleflex inc (TFX) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $826.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $441.5K
Executive Vice President and President of Ame...
Total Annual Compensation: $427.1K
Compensation as of Fiscal Year 2013.

teleflex inc (TFX) Key Developments

Teleflex Incorporated Signs New Agreement with Amerinet for Surgical Instruments

Teleflex Incorporated announced a new agreement with Amerinet for a comprehensive range of surgical instruments. The agreement is effective June 1, 2014 through March 31, 2017. Through this new agreement, Amerinet members will have access to an extensive line of handheld and laparoscopic surgical instruments, including well-established Pilling(R) and KMedic(R) products, at exclusive member rates.

Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter

Teleflex Incorporated received FDA 510(k) clearance to market its ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter. Designed by Dr. Timothy Clark, M.D., the VectorFlow(TM) Catheter features a symmetrical tip design that allows ease of placement and sustained high flows with minimal recirculation. The ARROW-Clark(TM) VectorFlow(TM) Catheter is the only catheter with an innovative tip designed to produce a helical, three-dimensional transition of blood entering and leaving the catheter.

Teleflex to Showcase Key Focus Anesthesia Products at Euroanesthesia 2014 in Stockholm

Teleflex announced that it will showcase its striking anesthesia portfolio, including regional anesthesia products, at the Euroanesthesia Congress in Stockholm, Sweden on May 31-June 3, 2014. In order to enable hands-on experience of the products,Teleflex will establish several interactive areas at its booth: Visitors will be offered the opportunity to take the LMA Supreme(TM) challenge. The main objective of the challenge is to prepare, lubricate and properly insert the LMA Supreme(TM) airway into the anatomical head following the 7 requisite steps in the correct order and in the least possible time. The easy placement of the newly designed EZ-BlockerTM bronchus blocker can be tested on a special tracheal model. The EZ-IO(R) Intraosseous (inside the bone) Vascular Access System that provides immediate vascular access for the delivery of essential medications and fluids will be demonstrated and can be tried out on bone models.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $106.36 USD -0.12

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hill-Rom Holdings Inc $40.12 USD +0.13
PerkinElmer Inc $47.72 USD +0.07
Sirona Dental Systems Inc $81.81 USD -0.10
STERIS Corp $53.27 USD -0.39
West Pharmaceutical Services Inc $40.45 USD -0.31
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 29.7x
Price/Sales 2.6x
Price/Book 2.3x
Price/Cash Flow 27.7x
TEV/Sales 1.6x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at